Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Affinity Capital Management Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Affinity Capital Management offers investment services to firms in the healthcare technology industry. It was founded in 1993 by Edson Spencer and is based in Minnesota.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2006 | Uptake Medical | Series A | 9M |
| 5/2012 | Sonitus Medical | Series D | 25M |
| 8/2000 | Ican | Venture Round | 4M |
| 8/2000 | Ican | Venture Round | 4M |
| 2/2009 | Primaeva Medical | Series C | 6M |
| 3/2012 | Uptake Medical | Series C | 40.3M |
| 3/2007 | Transoma Medical | Series C | 13M |
| 5/2004 | Disc Dynamics | Series E | 24M |
| 2/2000 | Agiliti | Series B | 0 |
| 9/2007 | Atritech | Series D | 22M |
| 1/2011 | Celleration | Series E | 0 |
| 4/2019 | ExplORer Surgical | Series A | 0 |
| 4/2008 | CoAxia | Series C | 11.5M |
| 11/2002 | Alliance Medical Corporation | Series E | 7.3M |
| 5/2009 | iScience Interventional | Series F | 20.5M |
| 9/2009 | ValenTx | Series B | 0 |
| 1/2008 | Arbor Surgical Technologies | Series C | 0 |
| 5/2007 | Pegasus Biologics | Series C | 20M |
| 9/2006 | CoAxia | Series C | 11M |
| 7/2002 | Celleration | Series B | 0 |
| 7/2010 | Uptake Medical | Series B | 17.5M |
| 6/2010 | Anulex Technologies | Series E | 18.3M |
| 4/2004 | NOVASYS MEDICAL | Series C | 25M |
| 4/2010 | Hemosphere | Series A | 9.3M |
| 3/2006 | Atritech | Series C | 22.5M |
| 12/2006 | Respicardia | Series A | 5.5M |
| 6/2009 | CoAxia | Series D | 21.5M |
| 1/2012 | iScience Interventional | Venture Round | 2.8M |
| 6/2010 | Baxano | Series C | 30M |
| 7/2006 | Anulex Technologies | Series C | 20M |
| 10/2005 | Transoma Medical | Series B | 12.7M |
| 10/2008 | Respicardia | Series B | 0 |
| 5/2009 | Anulex Technologies | Series D | 10.2M |
| 9/2013 | Respicardia | Series D | 10M |
| 8/2008 | Spineology | Series B | 1.5M |
| 5/2008 | Novasys Health | Venture Round | 49.5M |
| 5/2008 | Novasys Medical, Inc. | Series D | 49.5M |
| 9/2008 | Transoma Medical | Series D | 5M |
| 12/2004 | Transneuronix | Series B | 16.7M |
| 12/2004 | Myocor | Series D | 24M |
| 9/2001 | NOVASYS MEDICAL | Series B | 13M |
| 5/2007 | Pegasus Biologics | Series C | 20M |
| 8/2010 | Respicardia | Series C | 0 |
| 4/2019 | ExplORer Surgical | Series A | 0 |
| 9/2013 | Respicardia | Series D | 0 |
| 5/2012 | Sonitus Medical | Series D | 0 |
| 3/2012 | Uptake Medical | Series C | 0 |
| 1/2012 | iScience Interventional | Venture Round | 0 |
| 1/2011 | Celleration | Series E | 0 |
| 8/2010 | Respicardia | Series C | 0 |
| 7/2010 | Uptake Medical | Series B | 0 |
| 6/2010 | Baxano | Series C | 0 |
| 6/2010 | Anulex Technologies | Series E | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
